Request appointment
525 E 68th StSt341New York, NY 10065
Overview of Dr. Scandura
Dr. Joseph Scandura is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Lewis Katz School of Medicine at Temple University and has been in practice 29 years. Dr. Scandura accepts several types of health insurance, listed below. She is one of 403 doctors at New York-Presbyterian Hospital and one of 127 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 80 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2003
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1997 - 1999
Lewis Katz School of Medicine at Temple UniversityClass of 1997
Certifications & Licensure
NY State Medical License 1999 - 2026
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
Publications & Presentations
PubMed
- Epigenetic Priming with Azacitidine Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies.Mohammad Alhomoud, Franco Castillo Tokumori, Nora Chokr, Joshua Fein, Daniel C Choi
Transplantation and Cellular Therapy. 2026-08-15 - Between the classic hit and the modern sequel: transition dosing between peginterferon alfa-2a and ropeginterferon alfa-2b for myeloproliferative neoplasms.Ghaith Abu-Zeinah, Gabriela Hobbs, Brandi N Reeves, Abdulraheem Yacoub, Joseph M Scandura
Annals of Hematology. 2026-06-24 - Impact of Atrial Fibrillation on Thrombotic Complications in Myeloproliferative Neoplasms Real-World Analysis.Olga Demska, Jean-Christophe Ianotto, Marta Szandruk-Bender, Danijela Leković, Weronika Lebowa
Thrombosis and Haemostasis. 2026-05-13
Abstracts/Posters
- Low-Dose Epo after Tgf_ Blockade Triggers Robust Erythropoiesis and Increased RBC Production.Joseph Scandura, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Recombinant Interferon-_ Reduces Thrombotic Events in Patients with Polycythemia VeraJoseph Scandura, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall SurvivalJoseph Scandura, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Weill Cornell Team Creates Self-Renewing Hematopoietic Stem Cells for TransplantationMay 17th, 2017
New Method of Creating Blood Vessel Cells to Repair Injured TissuesJanuary 20th, 2017
Are You a Patient Taking Vidaza or Dacogen?February 8th, 2016
Grant Support
- Controlling the Niche to Control Clonal HematopoiesisWEILL MEDICAL COLL OF CORNELL UNIV2025–2029
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS California CaliforniaCare HMO
BCBS California PowerSelect HMO
BCBS California PPO
Blue Shield CA Local Access Plus HMO
Blue Shield California HMO
Blue Shield California PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMOEmpire BCBS PPO
GHI PPO
Great West PPO
Health Net California Large Group PPO
Health Net HMO - Employer Group
HIP of New York - Select PPO
Humana ChoiceCare Network PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
Pacificare HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
